Literature DB >> 20624924

Maternal neonaticide following traumatic childbirth: a case study.

Marc Nesca1, J Thomas Dalby.   

Abstract

Recent work has documented the relatively high incidence of Posttraumatic Stress Disorder (PTSD) symptoms in women during the birth delivery process and afterwards, even in uncomplicated births. This phenomenon, however, has yet to be linked with cases of neonaticide (child homicide in the first 24 hr of life) or infanticide (child homicide within the 1st year of life). Women are more likely to experience mental disorder after childbirth than at any other time in their lives, and the intentional killing of an offspring by a mentally ill mother is likely underreported. The immediate postpartum period is a time of heightened vigilance by health providers and, when the tragic death of an infant occurs, forensic professionals should specifically assess for PTSD. As an illustration, the authors present a case of maternal neonaticide that was directly linked to PTSD without any other concomitant mental disorder. PTSD is a viable mitigating factor to be examined in legal defenses of infanticide either in isolation or in conjunction with other factors.
© 2011 SAGE Publications

Entities:  

Mesh:

Year:  2010        PMID: 20624924     DOI: 10.1177/0306624X10376204

Source DB:  PubMed          Journal:  Int J Offender Ther Comp Criminol        ISSN: 0306-624X


  2 in total

1.  Post-traumatic Stress Disorder Post Partum: The Impact of Birth on the Prevalence of Post-traumatic Stress Disorder (PTSD) in Multiparous Women.

Authors:  W Schwab; C Marth; A M Bergant
Journal:  Geburtshilfe Frauenheilkd       Date:  2012-01       Impact factor: 2.915

2.  Assessment of major mental disorders in a German peripartum cardiomyopathy cohort.

Authors:  Tobias J Pfeffer; Julian Herrmann; Dominik Berliner; Tobias König; Lotta Winter; Melanie Ricke-Hoch; Evgeni Ponimaskin; Sven Schuchardt; Thomas Thum; Denise Hilfiker-Kleiner; Johann Bauersachs; Kai G Kahl
Journal:  ESC Heart Fail       Date:  2020-09-10
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.